Global Aortic Valve Replacement Companies
Aortic valve replacement, often abbreviated as AVR, is a medical procedure that entails the substitution of a sick or faulty aortic valve with a mechanical or biological replica. Aortic valve is one of the four valves of the heart situated between the left ventricle and the aorta, the largest artery in the body. Aortic valves are utilized to ensure that blood flows only in one direction, from the heart to the rest of the body. There are various different conditions that may require AVR. Firstly, aortic stenosis is the most common. In this condition, the aortic valve narrows and restricts blood from the heart to the rest of the body. It can occur as the aortic valve becomes calcified with age, from birth defects, or scarring resulting from an infection. Secondly, aortic regurgitation also known as aortic insufficiency. Over time, it eventually dilates and weakens the cardiac system. Moreover, some people are born with aortic valve abnormalities, such as Bicuspid aortic valve anomalies which have four leaflets, while normal AVS have three. The added leaflet makes the valve weaker, susceptible to wear and tear, and necessitates replacement.
The global aortic valve replacement market size reached US$ 10.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032.
Request For Sample Copy of Report For More Detailed Market insight: https://www.imarcgroup.com/aortic-valve-replacement-market/requestsample
Technological advancements pertaining to aortic valve replacement are mainly based on developments in technology or improvements of existing technology. Companies are investing heavily in research and development (R&D) activities to directly innovate new technologies and improve existing medical technologies to create advanced prosthetic valves that maintain durability and offer prolonged biocompatibility, in addition to the reduced risk of adverse effects due to human error. The introduction of transcatheter aortic valve replacement (TAVR) has forever changed the field using more careful surgical strategies to limit the involvement of the open-heart end.
Moreover, market leaders always implement additional strategies to further support the most comprehensive range of patients and medical professionals. More specifically, valve manufacturers are increasing the availability of prosthetic valves of mechanical, biological, bioprosthetic, and mechanical heart valve soakers for valve replacement, offering a variety of designs, sizes, and features to accommodate differences in patient types and preferences. To maximize the potential and focus resources, companies are increasingly partnering with other healthcare organizations, research institutions, and academic centers. Within the field of aortic valve replacement, companies are establishing collaborations based on expert exchange of knowledge and technology transfer to develop and innovate the best solution to replace the aorta.
Top 11 Aortic Valve Replacement Companies in the World:
- Abbott Laboratories
- Anteris Technologies Ltd.
- Boston Scientific Corporation
- Coroneo Inc.
- CryoLife Inc
- Edward Lifesciences Corporation
- JenaValve Technology Inc.
- LifeNet Health Inc.
- LivaNova PLC
- Medtronic plc
- Thubrikar Aortic Valve Inc
Explore Complete Blog by IMARC Group: https://www.imarcgroup.com/top-aortic-value-replacement-companies
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163